THMC Mental Health & Innovation Centre offers Multi-Protein Screening Blood Tests that detect Beta-amyloid and tau protein. Alzheimer’s disease is the most common form of dementia, accounting for approximately 60-70% of all dementia cases. Beta-amyloid and tau proteins accumulate in the brain of people with Alzheimer’s Disease 15 to 20 years before clinical symptoms of dementia. Our specialist in psychiatry will interpret the Multi-Protein Blood Test results with clinical assessment, cognitive assessment, as well as innovative and objective screening tests, including infrared brain scan and eye tracker test, to inform the client of the risk of Alzheimer’s disease and dementia.  For high-risk group, they can go for further assessment tests including MRI and PET scan.

 

Existing Alzheimer’s medications are most effective at the early stage, and our clinic offers oral and intravenous treatment for dementia and Alzheimer’s disease.